Visiting Clinical Professorship

The CAG Visiting Clinical Professorship award is offered annually to a member of CAG who is a proven educator and an outstanding clinician with interest in clinical research.

The recipient of this award will visit a minimum of six centres across Canada and depending upon their area of expertise, present education talks, engage in small group case-based discussions, demonstrate new endoscopic techniques or assist in quality assurance endeavors in the region. The CAG will support air travel and the host centres will be responsible for associated visit costs. The CAG Visiting Clinical Professor is available as a benefit to CAG members in the community.

For information on scheduling a visit to your centre please contact Joanne Ardron (CAG National Office).

 

2020 Award Recipient

Dr. John Marshall, McMaster University

Hamilton, ON

To request a visit, click here

We strongly suggest using the latest versions of Firefox, Safari or Google Chrome. Some Internet Explorer users may not be able to view all content nor access all functionality.

2020-2021 CAG Visiting Clinical Professor

JOHN MARSHALL MD MSc FRCPC

 

Dr. Marshall is a Professor of Medicine and Director of the Division of Gastroenterology at McMaster University, as well as a consultant gastroenterologist at Hamilton Health Sciences in Hamilton Ontario. He completed his B.A. and M.D. at Queen’s University, and then undertook his residency training and M.Sc. in Clinical Epidemiology & Biostatistics at McMaster University. He is a Full Member of the Farncombe Family Digestive Health Research Institute. His publications include over 200 academic papers and book chapters and over 250 abstracts. Dr. Marshall is the Editor-in-Chief of the Journal of the Canadian Association of Gastroenterology (JCAG). He is also an Associate Editor of ACP Journal Club and Evidence-Based Medicine, and an Editorial Board Member for the Journal of Crohn’s and Colitis. Past honours include the Canadian Association of Gastroenterology (CAG) Young Investigator Award (2008), the CAG Young Educator Award (2006), the CAG Visiting Clinical Professorship (2020), and Fellowship in both the American Gastroenterological Association (AGAF) and CAG (CAGF). Dr. Marshall’s clinical and research interests include inflammatory bowel disease, post-infectious irritable bowel syndrome, gastrointestinal bleeding, endoscopy, clinical trials, clinical epidemiology, health outcomes and health economics.

 

Potential topics of presentation:

  • Selected aspects or general review on inflammatory bowel disease epidemiology and management
  • Selected aspects or general review on functional bowel disorders including post-infectious irritable bowel syndrome
  • Selected aspects or general review of clinical practice guidelines
  • Selected review of medical publishing

Selected publications:

1. Marshall JK, Thabane M, Garg AX, Clark W, Salvadori M, Collins SM. Incidence and epidemiology of irritable bowel syndrome after a large waterborne outbreak of bacterial dysentery. Gastroenterology 2006;131:445-50.


2. Marshall JK, Thabane M, Borgaonkar M, James C. Post infectious irritable bowel syndrome following a foodborne outbreak of acute gastroenteritis attributed to a viral pathogen. Clin Gastroenterol Hepatol 2007;5:457-60.


3. Marshall JK, Thabane M, Steinhart AH, Newman J, Anand A, Irvine EJ. Rectal 5-aminosalicylic acid for induction of remission of ulcerative colitis. Cochrane Database Syst Rev 2010;CD004115.


4. Marshall JK, Thabane M, Garg AX, Clark WF, Moayyedi P, Collins SM. Eight-year prognosis of post-infectious irritable bowel syndrome following waterborne bacterial dysentery. Gut 2010;59:605-11. Commentary: Wang HW, Chang L. The Walkerton outbreak revisited at year 8: predictors, prevalence and prognosis of post-infectious IBS. Gastroenterology 2011;140:726-8.


5. Kassam Z, Hundal R, Marshall JK, Lee C. Fecal transplant via retention enema for refractory or recurrent Clostridium difficile infection. Arch Intern Med 2012;172:191-3.


6. Marshall JK, Thabane M, Steinhart AH, Newman JR, Anand A, Irvine EJ. Rectal 5-aminosalicylic acid for maintaining remission of distal ulcerative colitis. Cochrane Database Syst Rev 2012(11):CD004118.


7. Bollegala N, Brill H, Marshall JK. Resource utilization during pediatric to adult transfer of care in individuals with inflammatory bowel disease. J Crohn Colitis 2013;7:e55-60.


8. Bressler B*, Marshall JK*, Bernstein CN, Bitton A, Jones J, Leontiadis GL, Panaccione R, Steinhart AH, Tse F, Feagan B, Toronto Ulcerative Colitis Consensus Group. Clinical practice guidelines for the medical management of ulcerative colitis: the Toronto Consensus. Gastroenterology 2015;148:1035-58 (*co-principal authors).


9. Fallone CA, Chiba N, Veldhuyzen van Zanten S, Fischer L, Gisbert J, Hunt R, Jones N, Render C, Leontiadis G, Moayyedi P, Marshall JK. Clinical practice guidelines for the treatment of Helicobacter pylori infection: the Toronto consensus. Gastroenterology 2016;151:51-69.


10. Marshall JK, Bessette L, Shear NH, Lebovic G, Glass J, Millson B, Gaetano T, Gazel S, Latour MG, Laliberte MC, Thorne JC. Canada’s study of adherence outcomes in patients receiving adalimumab: 3-year results from the COMPANION study. Clin Ther 2018;40:1024-32.


11. Papp KA, Haraoui, B, Kumar D, Marshall JK, Bissonnette R, Bitton A, Bressler B, Gooderham M, Ho V, Jamal S, Pope JE, Steinhart AH, Vinh DC, Wade J. Vaccination guidelines for patients with immune-mediated disorders on immunosuppressive therapies. J Cutan Med Surg 2019;23:50-74.


12. Panaccione R, Steinhart AH, Bressler B, Khanna R, Marshall JK, Targownik L, Afif W, Bitton A, Borgaonkar M, Chauhan U, Halloran B, Jones J, Kennedy E, Leontiadis GI, Loftus EV, Meddings J, Moayyedi P, Murthy S, Plamandon S, Rosenfeld G, Schwartz D, Seow CH, Williams C, Bernstein CN. Clinical practice guideline for the management of luminal Crohn’s disease: the Toronto consensus. Clin Gastroenterol Hepatol 2019;17:1680-713.


13. Barkun AN, Almadi M, Kuipers EJ, Laine L, Sung J, Tse F, Leontiadis GI, Abraham NS, Calvet X, Chan FKL, Douketis J, Enns R, Gralnek IM, Jairath V, Jensen D, Lau J, Lip GYH, Loffroy R, Maluf-Filho F, Meltzer AC, Reddy N, Saltzmann JR, Marshall JK, Bardou M. Management of nonvariceal upper gastrointestinal bleeding: guideline recommendation from the International Consensus Group. Ann Intern Med 2020 [in press].


14. Sadowski D, Camilleri M, Chey WD, Leontiadis GI, Marshall JK, Shaffer E, Tse F, Walters JRF. Canadian Association of Gastroenterology clinical practice guideline on the management of bile acid diarrhea. Clin Gastroenterol Hepatol 2020;18:24-41.


15. Sands BE, Armuzzi A, Marshall JK, Lindsay JO, Sandborn WJ, Danese S, Panes J, Bressler B, Colombel JF, Lawendy N, Maller E, Zhang H, Chan G, Salese L, Tsilkos K, Marren A, Su C. Efficacy and safety of tofacitinib dose de-escalation and dose escalation for patients with ulcerative colitis: results from OCTAVE Open. Aliment Pharmacol Ther 2020;51:271-80.


16. Torres J, Bonovas S, Doherty G, Kucharzik T, Gisbert JP, Raine T, Adamina M, Armuzzi A, Bachmann O, Bager P, Biancone L, Bokemeyer B, Bossuyt P, Burisch J, Collins P, El-Hussuna A, Ellul P, Frei-Lanter C, Furfaro F, Gingert C, Gionchetti P, Gomollon F, González Lorenzo M, Gordon H, Hlavaty T, Juillerat P, Katsanos K, Kopylov U, Krustins E, Lytras T, Maaser C, Magro F, Marshall JK, Myrelid P, Pellino G, Rosa I, Sabino J, Savarino E, Spinelli A, Stassen L, Uzzan M, Vavricka S, Verstockt B, Warusavitarne J, Zmora O, Fiorino G, European Crohn’s and Colitis Organisation (ECCO). ECCO Guidelines on Therapeutics in Crohn’s Disease. Part 1: GRADE-based recommendation. J Crohn Colitis 2020;14:4-22.


17. Andrews CN, Sidani S, Marshall JK. Clinical management of the microbiome in irritable bowel syndrome. J Can Assoc Gastroenterol 2020 [in press].


18. Hughes A, Marshall J, Moretti M, Ungar WJ. A cost-utility analysis of biosimilar infliximab compared to reference infliximab in adult patients with Crohn’s disease. J Can Assoc Gastroenterol 2020 [in press].

 

 

 

Please submit this form if you are interested in having Dr. Marshall visit your centre.

Please click on the "Submit" button to submit your visit request for the CAG Visiting Clinical Professor. Before submitting, please ensure you have filled out all of the mandatory fields are correct.

Upon successful submission you will be directed to a webpage that confirms the successful submission and within a short period of time you will receive an email from the CAG National Office confirming receipt of your submission.  If this does not occur, please contact the CAG National Office.

NOTE: Upon submission do not close your browser or use the back button until the Thank you screen appears confirming your submission has gone through.

 

Application Process

Step One: Nomination - Deadline is September 30 11:59 PM ET

Please note that any submissions received after the deadline will be considered for the following year.

Nominators are required to submit an online nomination form. Nominators must be CAG members.

Submission Tips

PLEASE NOTE that you must submit the online application form INCLUDING uploading of all required documents (in .pdf format), in one single step; you are not able to save your application and return to it at a future date, rather it must be completed all at one time.

During your completion of the nomination form you will be asked to upload required documentation; you must have these .pdf documents prepared, finalized, and ready to upload when you begin the online form.
1. Letter of Support
2. CV of the Nominee

Upon successful submission you will be directed to a webpage that confirms the successful submission and within a short period of time you will receive an email from the CAG National Office confirming receipt of your submission. If this does not occur, please contact the CAG National Office immediately.

 

We strongly suggest using the latest versions of Firefox, Safari or Google Chrome. Some Internet Explorer users may not be able to view all content nor access all functionality. PLEASE ENSURE ALL ATTACHMENT FILE NAMES DO NOT CONTAIN SPECIAL CHARACTERS. This includes but is not limited to ! * # ; ? / : " < > |.

Nomination System is OPEN

Step Two: Review

The CAG Education Affairs Committee will review the nominations and make recommendations to the executive, who will make the final decision regarding recipients.

Step Three: Approval

Only the award recipient will be notified via email. The award is presented at CDDW™.

Previous Award Recipients